{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:11:02Z","timestamp":1786374662648,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol Exp"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study assessed the impact of structured reporting (SR) compared with conventional free-text reporting (FTR) on report quality for PSMA PET\/CT for diagnosis and staging of prostate cancer (PC) using a dedicated template.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>Fifty consecutive patients were included. Original clinical FTRs were compared with SRs retrospectively generated for the same examinations using template-based online software featuring clickable decision trees. Two readers specialised in urology and radioligand therapy independently assessed reports with regard to completeness, ease of information extraction, linguistic and overall report quality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      FTR achieved higher scores for overall report quality compared with SR (mean 5.46\n                      <jats:italic>versus<\/jats:italic>\n                      4.71;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001) and was associated with fewer missing key features (present in 36% of FTR\n                      <jats:italic>versus<\/jats:italic>\n                      54% of SR;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.005). Information was rated sufficient to guide decision-making regarding surgery\n                      <jats:italic>versus<\/jats:italic>\n                      conservative therapy in 91% of FTR compared to 76% of SR (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.018). Information extraction was rated easy in 69% of FTR compared to 50% of SRs (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.007). FTR received higher scores for linguistic quality (mean 5.69\n                      <jats:italic>versus<\/jats:italic>\n                      5.09;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). The key clinical questions were answered equally between reporting formats (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.68).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In PSMA PET\/CT reporting, FTR consistently achieved higher ratings than template-based SR, with respect to overall report quality, clinical usefulness for management decisions, information retrieval, and linguistic quality. These findings underline that the performance of SR strongly depends on template design, implementation workflow, and local reporting expertise, and that SR tools require careful, indication-specific validation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            <jats:bold>Question<\/jats:bold>\n                            Does SR improve the quality, completeness, interpretability, and clinical usefulness of PSMA PET\/CT reports for PC staging compared with FTR?\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            <jats:bold>Findings<\/jats:bold>\n                            FTR were rated superior to SR regarding clinical decision-making, completeness, report quality, and information retrieval.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            <jats:bold>Relevance statement<\/jats:bold>\n                            In PSMA PET\/CT, report format directly affects the usability of imaging findings for therapeutic decision-making. The effectiveness of SR appears dependent on local reporting expertise and clinical context, underscoring the need for prospective, indication-specific validation before routine clinical implementation.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41747-026-00777-0","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:04:50Z","timestamp":1786370690000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of structured reporting on interpretability of PSMA PET\/CT in prostate cancer staging\u2014towards standardised clinical implementation"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5161-9571","authenticated-orcid":false,"given":"Gloria","family":"Biechele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz","family":"Schnitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romy","family":"G\u00f6bel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Takayama","family":"Fouladgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Herr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirlind","family":"Zaganjori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien","family":"Holzgreve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Klimek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Cyran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Ricke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"R\u00fcbenthaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Geyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"777_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A (2024) Cancer statistics, 2024. CA Cancer J Clin 74:12\u201349. https:\/\/doi.org\/10.3322\/caac.21820","journal-title":"CA Cancer J Clin"},{"key":"777_CR2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","volume":"86","author":"P Cornford","year":"2024","unstructured":"Cornford P, van den Bergh RCN, Briers E et al (2024) EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer-2024 update. Part I: screening, diagnosis, and local treatment with curative intent. Eur Urol 86:148\u2013163. https:\/\/doi.org\/10.1016\/j.eururo.2024.03.027","journal-title":"Eur Urol"},{"key":"777_CR3","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1007\/s00259-022-06089-w","volume":"50","author":"WP Fendler","year":"2023","unstructured":"Fendler WP, Eiber M, Beheshti M et al (2023) PSMA PET\/CT: joint EANM procedure guideline\/SNMMI procedure standard for prostate cancer imaging 2.0. Eur J Nucl Med Mol Imaging 50:1466\u20131486. https:\/\/doi.org\/10.1007\/s00259-022-06089-w","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"777_CR4","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","volume":"395","author":"MS Hofman","year":"2020","unstructured":"Hofman MS, Lawrentschuk N, Francis RJ et al (2020) Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet 395:1208\u20131216. https:\/\/doi.org\/10.1016\/S0140-6736(20)30314-7","journal-title":"Lancet"},{"key":"777_CR5","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.1007\/s00261-023-04002-z","volume":"48","author":"S Houshmand","year":"2023","unstructured":"Houshmand S, Lawhn-Heath C, Behr S (2023) PSMA PET imaging in the diagnosis and management of prostate cancer. Abdom Radiol (NY) 48:3610\u20133623. https:\/\/doi.org\/10.1007\/s00261-023-04002-z","journal-title":"Abdom Radiol (NY)"},{"key":"777_CR6","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2967\/jnumed.117.197160","volume":"59","author":"PJ Roach","year":"2018","unstructured":"Roach PJ, Francis R, Emmett L et al (2018) The impact of 68Ga-PSMA PET\/CT on management intent in prostate cancer: results of an Australian prospective multicenter study. J Nucl Med 59:82\u201388. https:\/\/doi.org\/10.2967\/jnumed.117.197160","journal-title":"J Nucl Med"},{"key":"777_CR7","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.2967\/jnumed.117.196683","volume":"58","author":"L Emmett","year":"2017","unstructured":"Emmett L, van Leeuwen PJ, Nandurkar R et al (2017) Treatment outcomes from 68Ga-PSMA PET\/CT-informed salvage radiation treatment in men with rising PSA after radical prostatectomy: prognostic value of a negative PSMA PET. J Nucl Med 58:1972\u20131976. https:\/\/doi.org\/10.2967\/jnumed.117.196683","journal-title":"J Nucl Med"},{"key":"777_CR8","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S1470-2045(22)00605-2","volume":"23","author":"JP Buteau","year":"2022","unstructured":"Buteau JP, Martin AJ, Emmett L et al (2022) PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [177Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trial. Lancet Oncol 23:1389\u20131397. https:\/\/doi.org\/10.1016\/S1470-2045(22)00605-2","journal-title":"Lancet Oncol"},{"key":"777_CR9","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1007\/s00259-023-06287-0","volume":"50","author":"F Gelardi","year":"2023","unstructured":"Gelardi F, Briganti A, Pini C et al (2023) European guidelines update on PSMA PET\/CT for prostate cancer staging - snap back to reality. Eur J Nucl Med Mol Imaging 50:2572\u20132575. https:\/\/doi.org\/10.1007\/s00259-023-06287-0","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"777_CR10","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1148\/radiol.14141227","volume":"273","author":"TA Morgan","year":"2014","unstructured":"Morgan TA, Helibrun ME, Kahn CE Jr (2014) Reporting initiative of the Radiological Society of North America: progress and new directions. Radiology 273:642\u2013645. https:\/\/doi.org\/10.1148\/radiol.14141227","journal-title":"Radiology"},{"key":"777_CR11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s13244-011-0066-7","volume":"2","author":"European Society of Radiology (ESR)","year":"2011","unstructured":"European Society of Radiology (ESR) (2011) Good practice for radiological reporting. Guidelines from the European Society of Radiology (ESR). Insights Imaging 2:93\u201396. https:\/\/doi.org\/10.1007\/s13244-011-0066-7","journal-title":"Insights Imaging"},{"key":"777_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12880-019-0325-5","volume":"19","author":"BP Ernst","year":"2019","unstructured":"Ernst BP, Hodeib M, Strieth S et al (2019) Structured reporting of head and neck ultrasound examinations. BMC Med Imaging 19:25. https:\/\/doi.org\/10.1186\/s12880-019-0325-5","journal-title":"BMC Med Imaging"},{"key":"777_CR13","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.jcct.2017.02.008","volume":"11","author":"BO Sabel","year":"2017","unstructured":"Sabel BO, Plum JL, Kneidinger N et al (2017) Structured reporting of CT examinations in acute pulmonary embolism. J Cardiovasc Comput Tomogr 11:188\u2013195. https:\/\/doi.org\/10.1016\/j.jcct.2017.02.008","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"777_CR14","doi-asserted-by":"publisher","first-page":"534","DOI":"10.3390\/cancers13030534","volume":"13","author":"T Geyer","year":"2021","unstructured":"Geyer T, R\u00fcbenthaler J, Marschner C et al (2021) Structured reporting using CEUS LI-RADS for the diagnosis of hepatocellular carcinoma (HCC)\u2014impact and advantages on report integrity, quality and interdisciplinary communication. Cancers (Basel) 13:534. https:\/\/doi.org\/10.3390\/cancers13030534","journal-title":"Cancers (Basel)"},{"key":"777_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13244-017-0588-8","volume":"9","author":"European Society of Radiology (ESR)","year":"2018","unstructured":"European Society of Radiology (ESR) (2018) ESR paper on structured reporting in radiology. Insights Imaging 9:1\u20137. https:\/\/doi.org\/10.1007\/s13244-017-0588-8","journal-title":"Insights Imaging"},{"key":"777_CR16","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1007\/s10278-009-9239-z","volume":"22","author":"BI Reiner","year":"2009","unstructured":"Reiner BI (2009) The challenges, opportunities, and imperative of structured reporting in medical imaging. J Digit Imaging 22:562\u2013568. https:\/\/doi.org\/10.1007\/s10278-009-9239-z","journal-title":"J Digit Imaging"},{"key":"777_CR17","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1007\/s00330-021-08327-5","volume":"32","author":"JM Nobel","year":"2022","unstructured":"Nobel JM, van Geel K, Robben SGF (2022) Structured reporting in radiology: a systematic review to explore its potential. Eur Radiol 32:2837\u20132854. https:\/\/doi.org\/10.1007\/s00330-021-08327-5","journal-title":"Eur Radiol"},{"key":"777_CR18","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.2214\/AJR.17.18410","volume":"209","author":"CI Lee","year":"2017","unstructured":"Lee CI, Lee JM (2017) Maximizing value through innovations in radiologist-driven communications in breast imaging. AJR Am J Roentgenol 209:1001\u20131005. https:\/\/doi.org\/10.2214\/AJR.17.18410","journal-title":"AJR Am J Roentgenol"},{"key":"777_CR19","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.eururo.2017.10.027","volume":"73","author":"SP Rowe","year":"2018","unstructured":"Rowe SP, Pienta KJ, Pomper MG, Gorin MA (2018) PSMA-RADS version 1.0: a step towards standardizing the interpretation and reporting of PSMA-targeted PET imaging studies. Eur Urol 73:485\u2013487. https:\/\/doi.org\/10.1016\/j.eururo.2017.10.027","journal-title":"Eur Urol"},{"key":"777_CR20","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s00261-025-05068-7","volume":"51","author":"A Elsamny","year":"2026","unstructured":"Elsamny A, Wardeh A, Panyukova A et al (2026) PSMA-RADS 2.0: a revised framework for PSMA-targeted imaging interpretation and clinical decision-making. Abdom Radiol (NY) 51:180\u2013192. https:\/\/doi.org\/10.1007\/s00261-025-05068-7","journal-title":"Abdom Radiol (NY)"},{"key":"777_CR21","doi-asserted-by":"publisher","first-page":"469","DOI":"10.2967\/jnumed.117.198119","volume":"59","author":"M Eiber","year":"2018","unstructured":"Eiber M, Herrmann K, Calais J et al (2018) Prostate cancer molecular imaging standardized evaluation (PROMISE): proposed miTNM classification for the interpretation of PSMA-ligand PET\/CT. J Nucl Med 59:469\u2013478. https:\/\/doi.org\/10.2967\/jnumed.117.198119","journal-title":"J Nucl Med"},{"key":"777_CR22","doi-asserted-by":"publisher","first-page":"1695707","DOI":"10.3389\/fdmed.2025.1695707","volume":"6","author":"ML Schnitzer","year":"2025","unstructured":"Schnitzer ML, Forster A-L, Biechele G et al (2025) Structured reporting enhances diagnostic quality in periapical dental radiographs: a comparative evaluation. Front Dent Med 6:1695707. https:\/\/doi.org\/10.3389\/fdmed.2025.1695707","journal-title":"Front Dent Med"},{"key":"777_CR23","doi-asserted-by":"publisher","first-page":"4793","DOI":"10.1038\/s41598-025-88999-x","volume":"15","author":"A Hinterberger","year":"2025","unstructured":"Hinterberger A, Trupka L, Kortbein S et al (2025) Structured reporting of neuroendocrine tumors in PET\/CT using [18F]SiTATE - impact on interdisciplinary communication. Sci Rep 15:4793. https:\/\/doi.org\/10.1038\/s41598-025-88999-x","journal-title":"Sci Rep"},{"key":"777_CR24","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/RLI.0000000000000336","volume":"52","author":"D N\u00f6renberg","year":"2017","unstructured":"N\u00f6renberg D, Sommer WH, Thasler W et al (2017) Structured reporting of rectal magnetic resonance imaging in suspected primary rectal cancer: potential benefits for surgical planning and interdisciplinary communication. Invest Radiol 52:232\u2013239. https:\/\/doi.org\/10.1097\/RLI.0000000000000336","journal-title":"Invest Radiol"},{"key":"777_CR25","doi-asserted-by":"publisher","first-page":"425","DOI":"10.2967\/jnumed.116.181768","volume":"58","author":"J Cardinale","year":"2017","unstructured":"Cardinale J, Sch\u00e4fer M, Bene\u0161ov\u00e1 M et al (2017) Preclinical evaluation of 18F-PSMA-1007, a new prostate-specific membrane antigen ligand for prostate cancer imaging. J Nucl Med 58:425\u2013431. https:\/\/doi.org\/10.2967\/jnumed.116.181768","journal-title":"J Nucl Med"},{"key":"777_CR26","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00259-024-06857-w","volume":"52","author":"SA Esfahani","year":"2024","unstructured":"Esfahani SA, Morris MJ, Sartor O et al (2024) Standardized template for clinical reporting of PSMA PET\/CT scans. Eur J Nucl Med Mol Imaging 52:335\u2013341. https:\/\/doi.org\/10.1007\/s00259-024-06857-w","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"777_CR27","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.eururo.2023.06.008","volume":"84","author":"RA Werner","year":"2023","unstructured":"Werner RA, Hartrampf PE, Fendler WP et al (2023) Prostate-specific membrane antigen reporting and data system version 2.0. Eur Urol 84:491\u2013502. https:\/\/doi.org\/10.1016\/j.eururo.2023.06.008","journal-title":"Eur Urol"},{"key":"777_CR28","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3390\/diagnostics11020313","volume":"11","author":"ML Schnitzer","year":"2021","unstructured":"Schnitzer ML, Sabel L, Schwarze V et al (2021) Structured reporting in the characterization of renal cysts by contrast-enhanced ultrasound (CEUS) using the Bosniak classification system - improvement of report quality and interdisciplinary communication. Diagnostics (Basel) 11:313. https:\/\/doi.org\/10.3390\/diagnostics11020313","journal-title":"Diagnostics (Basel)"},{"key":"777_CR29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/diagnostics11010035","volume":"11","author":"T Geyer","year":"2020","unstructured":"Geyer T, Clevert D-A, Schwarz S et al (2020) Diagnostic value of CEUS prompting liver biopsy: histopathological correlation of hepatic lesions with ambiguous imaging characteristics. Diagnostics (Basel) 11:35. https:\/\/doi.org\/10.3390\/diagnostics11010035","journal-title":"Diagnostics (Basel)"},{"key":"777_CR30","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1007\/s11548-018-1828-1","volume":"13","author":"M Armbruster","year":"2018","unstructured":"Armbruster M, Gassenmaier S, Haack M et al (2018) Structured reporting in petrous bone MRI examinations: impact on report completeness and quality. Int J Comput Assist Radiol Surg 13:1971\u20131980. https:\/\/doi.org\/10.1007\/s11548-018-1828-1","journal-title":"Int J Comput Assist Radiol Surg"},{"key":"777_CR31","doi-asserted-by":"publisher","first-page":"3969","DOI":"10.1007\/s00261-020-02720-2","volume":"45","author":"H Shaish","year":"2020","unstructured":"Shaish H (2020) Structured prostate MRI reporting: how and why. Abdom Radiol (NY) 45:3969\u20133973. https:\/\/doi.org\/10.1007\/s00261-020-02720-2","journal-title":"Abdom Radiol (NY)"},{"key":"777_CR32","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1007\/s00330-018-5340-3","volume":"28","author":"F Schoeppe","year":"2018","unstructured":"Schoeppe F, Sommer WH, N\u00f6renberg D et al (2018) Structured reporting adds clinical value in primary CT staging of diffuse large B-cell lymphoma. Eur Radiol 28:3702\u20133709. https:\/\/doi.org\/10.1007\/s00330-018-5340-3","journal-title":"Eur Radiol"},{"key":"777_CR33","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.eururo.2023.02.002","volume":"83","author":"R Seifert","year":"2023","unstructured":"Seifert R, Emmett L, Rowe SP et al (2023) Second version of the prostate cancer molecular imaging standardized evaluation framework including response evaluation for clinical trials (PROMISE V2). Eur Urol 83:405\u2013412. https:\/\/doi.org\/10.1016\/j.eururo.2023.02.002","journal-title":"Eur Urol"},{"key":"777_CR34","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.250702","volume":"317","author":"HA Vargas","year":"2025","unstructured":"Vargas HA, Fanti S, Herrmann K et al (2025) PSMA PET\/CT reporting: real-life inconsistencies, heterogeneity, and underutilization of scoring systems and interpretation frameworks. Radiology 317:e250702. https:\/\/doi.org\/10.1148\/radiol.250702","journal-title":"Radiology"},{"key":"777_CR35","doi-asserted-by":"publisher","unstructured":"Spitzl D, Mergen M, Endroes L et al (2026) LLM-powered prostate cancer staging from PSMA-PET\/CT reports using PROMISE v2. Eur J Nucl Med Mol Imaging. https:\/\/doi.org\/10.1007\/s00259-026-07847-w","DOI":"10.1007\/s00259-026-07847-w"}],"container-title":["European Radiology Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41747-026-00777-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41747-026-00777-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41747-026-00777-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:04:51Z","timestamp":1786370691000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41747-026-00777-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["777"],"URL":"https:\/\/doi.org\/10.1186\/s41747-026-00777-0","relation":{},"ISSN":["2509-9280"],"issn-type":[{"value":"2509-9280","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"assertion":[{"value":"24 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective single-centre study was approved by the institutional review board (Ethics Committee, Medical Faculty, Ludwig Maximilian University (LMU) Munich; 20-1077; date of approval: 19 December 2020). Informed consent was waived.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Johannes R\u00fcbenthaler declares ownership of shares in Siemens Healthineers. Johannes R\u00fcbenthaler is a member of the\n                      Advisory Editorial Board\n                      of the ESR Journals. They have not taken part in the review or selection process of this article.","order":3,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"113"}}